Vaccination trials on gilthead seabream (Sparus aurata) against Pasteurella piscicida

A comparative study of the efficacy of two vaccine formulations, a whole-cell bacterin (WCB) and a toxoid-enriched whole-cell vaccine (WCEB), against Pasteurella piscicida was conducted by bath immersion in gilthead seabream in order to evaluate the role of the extracellular products (ECP) as protective antigens against this pathogen. With this aim, two strains showing differences in their ECP composition were used to prepare both vaccines. Only the toxoid-enriched vaccine conferred protection against P. piscicida within a 4-week period. The relative percent survival (RPS) acheived with this type of vaccine ranged between 37 and 41 depending on the bacterial strain and dose used in the challenge. Although this protection level is not very high, we consider that it is valuable considering the economic importance of the fish susceptible to pasteurellosis throughout the world. The booster immunization with the WCEB P. piscicida formulation did not increase the protection levels of gilthead seabream. The antibody response in the sera of both immunized fish groups was very low with no correlation between the level of agglutinating antibodies and the protection. In addition, this vaccine did not confer cross-protection against serotypes 01 and 02 of Vibrio anguillarum.